- Home
- CROX vs BIO Comparison
CROX vs BIO Comparison
Compare CROX & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CROX | BIO |
|---|---|---|
| Founded | 1999 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Shoe Manufacturing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 7.1B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | CROX | BIO |
|---|---|---|
| Price | $79.35 | $276.61 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 4 |
| Target Price | $94.44 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 1.1M | 255.1K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,040,647,000.00 | N/A |
| Revenue This Year | $1.89 | $2.74 |
| Revenue Next Year | $2.48 | $3.05 |
| P/E Ratio | ★ N/A | $9.72 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $73.21 | $211.43 |
| 52 Week High | $116.11 | $343.12 |
Technical Indicators
Market Signals| Indicator | CROX | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 53.11 |
| Support Level | $74.92 | $266.71 |
| Resistance Level | $88.20 | $289.61 |
| Average True Range (ATR) | 2.74 | 7.47 |
| MACD | -0.03 | 1.90 |
| Stochastic Oscillator | 31.65 | 93.96 |
Price Performance
Historical ComparisonAbout CROX Crocs Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable operating segments of the company are the Crocs Brand and the HEYDUDE Brand. The company derives maximum revenue from the Crocs brand segment.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.